Opinion: When my child is in psychosis, the pediatric health care system can’t help us
Strategic angle: “There is no off switch when the crisis is your child,” writes Liz Koch.
Editorial Staff Apr 6
Health
Latest Health stories from Life.
Briefing: UnitedHealth Group is making a $3 billion bet on AI. What does it mean for patients?
Strategic angle: UnitedHealth Group is rapidly deploying artificial intelligence tools across its operations. What does it mean for patients?
Editorial Staff Apr 6
What the peptide craze reveals about Americans’ relationship with risk
Strategic angle: Why do RFK Jr. and other health influencers embrace unproven peptides while calling for more research into well-studied vaccines?
Editorial Staff Apr 6
Briefing: NIH Faces $5 Billion Cut in Trump's 2027 Budget Proposal
Strategic angle: Congress is expected to resist the proposed reduction in funding for the National Institutes of Health.
Editorial Staff Apr 3
Briefing: White House Proposes 12% Cut to Federal Health Agencies in 2027 Budget Request
Strategic angle: The proposal comes as Congress previously ignored similar cuts, opting instead to increase health spending.
Editorial Staff Apr 3
Briefing: Biotech Investors Urge Trump Amid M&A Activity
Strategic angle: Smaller biotechs negotiate with the White House while addressing the trust gap in medicine.
Editorial Staff Apr 3
Trump announces 100% tariffs on brand-name drugs, with plenty of carveouts
The taxes are part of the president's push to rein in the pharmaceutical industry and bring manufacturing to the U.S.
Editorial Staff Apr 3
Briefing: Thursday was World Autism Awareness Day. HHS celebrated with…a workout?
Strategic angle: Implications of SCOTUS' conversion therapy ruling, Trump hikes drug tariffs, and more Morning Rounds updates
Editorial Staff Apr 3
Briefing: Opinion: My patient would rather take a peptide than a statin. That reveals an uncomfortable truth in medicine
Strategic angle: “The volume of evidence behind a therapy has become inversely correlated with public trust in it,” writes Vikas Patel.
Editorial Staff Apr 3
Briefing: Opinion: Subscription pricing could expand access to HIV prevention breakthrough while controlling costs
Strategic angle: Lenacapavir could put the end of the HIV epidemic in reach — if the people who need it can access it. Here’s one way to make that happen.
Editorial Staff Apr 3
Briefing: Supreme Court conversion therapy decision could ripple through medicine
Strategic angle: A Supreme Court ruling this week on gender and sexuality 'conversion therapy' could narrow the authority of state medical boards over care involving speech.
Editorial Staff Apr 3
Supreme Court rules against Colorado ban on ‘conversion therapy’ for LGBTQ kids
The Supreme Court's decision challenges state laws against a discredited practice aimed at LGBTQ+ youth.
Editorial Staff Apr 3
Briefing: Medicare Advantage plans win extra $18.6 billion as feds cut star ratings measures
Strategic angle: CMS is scaling back the number of measures it uses to grade health insurers.
Editorial Staff Apr 2
Briefing: Small Drugmakers Negotiate Pricing Deals Amid Tariff Threat
Strategic angle: The Trump administration is in talks with smaller pharmaceutical companies to establish new drug-pricing agreements.
Editorial Staff Apr 2
Briefing: Biotech investors’ plea to Trump, and a busy M&A week
Strategic angle: How has the FDA's recent decisions on rare disease drugs affected investment trends? Why is Eli Lilly getting into sleep medicine?
Editorial Staff Apr 2
Briefing: FDA’s Evolving View of What Makes a ‘Breakthrough’ Device
Strategic angle: An analysis of AI-powered devices that received the FDA's 'breakthrough' label.
Editorial Staff Apr 2
Briefing: How health care could gum up Trump’s reconciliation push
Strategic angle: Cuts to health care spending might play a role in a complicated Congressional maneuver to fund immigration enforcement.
Editorial Staff Apr 2
Briefing: Lilly’s obesity pill enters the oral GLP-1 game, Novo responds
Strategic angle: Potential import tariffs on drugs, Foundayo is here-o, and other biotech news from The Readout
Editorial Staff Apr 2
Briefing: Trump Administration Plans 100% Tariff on Patented Medicines
Strategic angle: The FDA approves a new obesity pill from Lilly amidst tariff discussions.
Editorial Staff Apr 2
Briefing: A Preview of the Role Health Care May Play in the 2026 Election
Strategic angle: Ahead of the 2026 midterm elections, this KFF issue brief examines the role health care has played in previous elections and its potential impact in 2026.
Editorial Staff Apr 2